|
|
Blood, 15 October 2005, Vol. 106, No. 8, pp. 2781-2789.
Prepublished online as a Blood First Edition Paper on July 5, 2005; DOI 10.1182/blood-2005-02-0597.
Previous Article | Next Article 
Submitted February 11, 2005
Accepted April 27, 2005
An alternative exon 1 of the cd5 gene regulates CD5 expression in human B lymphocytes
Yves Renaudineau, Sophie Hillion, Alain Saraux, Rizgar A Mageed, and Pierre Youinou*
Laboratory of Immunology, Brest University Medical School, Brest, France
William Harvey Research Institute, Queen Mary School of Medicine, London, United Kingdom
* Corresponding author; email: youinou{at}univ-brest.fr.
T lymphocytes and a subpopulation of B lymphocytes express the CD5 co-receptor. Its functional importance is evident from the multiple levels and developmental stages of the regulation of its expression. We report the discovery of a novel regulatory exon upstream of the non-coding region of the cd5 gene in humans. This alternate exon 1 is designated E1B (with the conventional exon 1 renamed E1A), and shown to regulate the expression of CD5. E1B-containing transcripts exist exclusively in B lymphocytes, encode a protein which is truncated, and retained intracellularly. As a consequence, the amount of E1A-containing transcripts is down-regulated, and the membrane CD5 expression diminished in the presence of E1B-containing transcripts. High levels of E1A-transcripts were found in chronic lymphocytic leukemia, and there were no E1A-transcripts in 697 pre-B cells which have no membrane CD5. Introduc-tion of E1B into Jurkat cells reduces their membrane expression of CD5, and sequence analysis reveals that the E1B motif is a defective human endogenous retrovirus. A balance between the 2 alternative exons 1 might be central to the regulation of membrane CD5 in human B cells, and, through CD5-associated SH2-containing phosphatase 1, to the modulation of B cell antigen receptor-transduced signals.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Garaud, C. Le Dantec, S. Jousse-Joulin, C. Hanrotel-Saliou, A. Saraux, R. A. Mageed, P. Youinou, and Y. Renaudineau
IL-6 Modulates CD5 Expression in B Cells from Patients with Lupus by Regulating DNA Methylation
J. Immunol.,
May 1, 2009;
182(9):
5623 - 5632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Shani, H. Rubin-Lifshitz, Y. Peretz-Cohen, K. Shkolnik, V. Shinder, M. Cohen-Sfady, Y. Shav-Tal, M. Barda-Saad, and D. Zipori
Incomplete T-cell receptor-{beta} peptides target the mitochondrion and induce apoptosis
Blood,
April 9, 2009;
113(15):
3530 - 3541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Garaud, C. Le Dantec, C. Berthou, P. M. Lydyard, P. Youinou, and Y. Renaudineau
Selection of the Alternative Exon 1 from the cd5 Gene Down-Regulates Membrane Level of the Protein in B Lymphocytes
J. Immunol.,
August 1, 2008;
181(3):
2010 - 2018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Williams
Stay Away From Self: 5th International Congress on Autoimmunity, Sorrento, Italy, November 29-December 3, 2006
J. Exp. Med.,
March 19, 2007;
204(3):
456 - 457.
[Full Text]
[PDF]
|
 |
|
|
|